PMID: 41681940

Comparison Between Alpelisib Plus Endocrine Therapy and Everolimus Plus Endocrine Therapy After CDK4/6 Inhibitors Progression in Patients with PIK3CA -Mutant Metastatic Breast Cancer: A Single-Center Retrospective Study.

Loizidis Sotiris, Michaelides Damianos, Marcou Yiola, Kakouri Eleni, Konstantinou Ifigenia, Constantinidou Anastasia, Theophanous-Kitiri Stavroula, Papageorgiou Elisavet, Michailidou Kyriaki, Galazi Myria

Cancers · 2026

Vol. 18, Issue 3

View on PubMed DOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.